CD84
Basic information
Region (hg38): 1:160541094-160579516
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (14 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CD84 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 14 | 14 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region ? | 0 | |||||
non coding ? | 0 | |||||
Total | 0 | 0 | 14 | 0 | 0 |
Variants in CD84
This is a list of pathogenic ClinVar variants found in the CD84 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-160548308-C-T | not specified | Uncertain significance (Apr 19, 2023) | ||
1-160549934-C-T | not specified | Uncertain significance (Jul 05, 2023) | ||
1-160549952-T-C | not specified | Uncertain significance (Nov 14, 2023) | ||
1-160551014-A-G | not specified | Uncertain significance (Jan 08, 2024) | ||
1-160553423-T-C | not specified | Uncertain significance (Feb 12, 2024) | ||
1-160553453-C-T | not specified | Uncertain significance (Jul 13, 2021) | ||
1-160553480-G-A | not specified | Uncertain significance (Aug 17, 2021) | ||
1-160553492-C-T | not specified | Uncertain significance (Jan 26, 2023) | ||
1-160553910-G-A | not specified | Uncertain significance (Feb 06, 2023) | ||
1-160553915-G-A | not specified | Uncertain significance (Apr 07, 2022) | ||
1-160553985-G-C | not specified | Uncertain significance (Aug 09, 2021) | ||
1-160554083-A-C | not specified | Uncertain significance (Nov 30, 2022) | ||
1-160565461-T-A | not specified | Uncertain significance (Aug 02, 2023) | ||
1-160565472-TA-T | Multisystem inflammatory syndrome in children | risk factor (Nov 14, 2021) | ||
1-160565515-T-A | not specified | Uncertain significance (Dec 20, 2023) | ||
1-160565523-G-A | not specified | Uncertain significance (Apr 08, 2022) | ||
1-160565548-A-C | not specified | Uncertain significance (Feb 15, 2023) | ||
1-160565577-G-A | not specified | Uncertain significance (Jul 13, 2021) | ||
1-160565601-G-T | not specified | Uncertain significance (Dec 11, 2023) | ||
1-160579424-T-A | not specified | Uncertain significance (Dec 28, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CD84 | protein_coding | protein_coding | ENST00000311224 | 8 | 38422 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
6.91e-9 | 0.262 | 125689 | 0 | 57 | 125746 | 0.000227 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.216 | 184 | 192 | 0.956 | 0.0000103 | 2243 |
Missense in Polyphen | 40 | 47.599 | 0.84036 | 595 | ||
Synonymous | -0.271 | 75 | 72.1 | 1.04 | 0.00000394 | 679 |
Loss of Function | 0.595 | 14 | 16.6 | 0.843 | 7.98e-7 | 202 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000181 | 0.000181 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000167 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000348 | 0.000325 |
Middle Eastern | 0.000167 | 0.000163 |
South Asian | 0.000399 | 0.000359 |
Other | 0.000340 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. SLAM receptors triggered by homo- or heterotypic cell-cell interactions are modulating the activation and differentiation of a wide variety of immune cells and thus are involved in the regulation and interconnection of both innate and adaptive immune response. Activities are controlled by presence or absence of small cytoplasmic adapter proteins, SH2D1A/SAP and/or SH2D1B/EAT-2. Can mediate natural killer (NK) cell cytotoxicity dependent on SH2D1A and SH2D1B (By similarity). Increases proliferative responses of activated T- cells and SH2D1A/SAP does not seem be required for this process. Homophilic interactions enhance interferon gamma/IFNG secretion in lymphocytes and induce platelet stimulation via a SH2D1A-dependent pathway. May serve as a marker for hematopoietic progenitor cells (PubMed:11564780, PubMed:12115647. PubMed:12928397, PubMed:12962726, PubMed:16037392) Required for a prolonged T- cell:B-cell contact, optimal T follicular helper function, and germinal center formation. In germinal centers involved in maintaining B-cell tolerance and in preventing autoimmunity (By similarity). In mast cells negatively regulates high affinity immunoglobulin epsilon receptor signaling; independent of SH2D1A and SH2D1B but implicating FES and PTPN6/SHP-1 (PubMed:22068234). In macrophages enhances LPS-induced MAPK phosphorylation and NF- kappaB activation and modulates LPS-induced cytokine secretion; involving ITSM 2 (By similarity). Positively regulates macroautophagy in primary dendritic cells via stabilization of IRF8; inhibits TRIM21-mediated proteasomal degradation of IRF8 (PubMed:29434592). {ECO:0000250|UniProtKB:Q18PI6, ECO:0000269|PubMed:11564780, ECO:0000269|PubMed:12115647, ECO:0000269|PubMed:12928397, ECO:0000269|PubMed:12962726, ECO:0000269|PubMed:16037392, ECO:0000269|PubMed:22068234, ECO:0000269|PubMed:29434592, ECO:0000305}.;
- Pathway
- TYROBP Causal Network;TCR;Cell surface interactions at the vascular wall;Hemostasis
(Consensus)
Recessive Scores
- pRec
- 0.138
Intolerance Scores
- loftool
- 0.925
- rvis_EVS
- 0.04
- rvis_percentile_EVS
- 57.15
Haploinsufficiency Scores
- pHI
- 0.0662
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.488
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0768
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cd84
- Phenotype
- immune system phenotype; hematopoietic system phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- adaptive immune response;autophagy;defense response;homophilic cell adhesion via plasma membrane adhesion molecules;negative regulation of granulocyte macrophage colony-stimulating factor production;negative regulation of interleukin-18 production;negative regulation of mast cell activation;negative regulation of mast cell degranulation;innate immune response;leukocyte migration;regulation of store-operated calcium entry
- Cellular component
- plasma membrane;integral component of plasma membrane
- Molecular function
- protein binding;identical protein binding